Vitreous hemorrhage secondary to ruptured intracranial aneurysm

1. A case of a verified ruptured aneurysm of the intracranial portion of the internal carotid artery with extensive bilateral vitreous hemorrhage leading to marked impairment of vision is reported2. The subject of the pathogenesis of intraocular hemorrhages occurring in spontaneous subarachnoid bleeding is reviewed. (Summary)

Aids in the diagnosis of neurological diseases from the point of view of the general practice

1. A complete clinical history and a thorough neurological examination enables us in the majority of cases to localize the anatomical neurological lesion2. However, we need aids to establish the nature of the anatomical neurological lesion before we can institute treatment3. The arteriogram, ventriculogram and myelogram are three of the most useful diagnostic neurological procedures that help us establish the nature of the neurological lesion, particularly whether it is space-occupying or not. (Summary)

The symptomatology of cerebrovascular disease

1. Symptoms and signs of cerebral transient ischemic attacks, cerebral thrombosis, hemorrhage and embolism may be difficult to differentiate clinically due to their close similarity2. Similarly, other neurological diseases like cerebral aneurysms, angiomas, subdural hematomas and brain tumors may have identical symptoms and signs as the cerebrovascular strokes or episodes3. In the above situations, a cerebral angiogram can help very much in the diagnosis and elucidation of the specific neurological disease. (Summary)

Clinical experiences with the use of mannitol as an agent to reduce intracranial pressure - a preliminary report

Twenty-one patients with increased intracranial pressure were given Mannitol (20% and 25% intravenously at a dose ranging from 1 to 1.5 grams per kilogram body weight). Fifteen of these patients showed reduction of intracranial pressure as shown by recession of the surface of the cerebral cortex during craniotomies, and the remaining 5 cases, except one, showed diminution of the size of the pupil. The case which showed no change in the size of the pupils postoperatively was the first case where Mannitol was given at a dose of .5 gms/kg body weightThis encouraging result should merit further controlled clinical trials of the drug. (Summary)